Main Subject - Business

JV Mailings – For certain product or service offerings, direct mail can be prohibitively expensiv

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e. That’s why card decks and Value-Paks are so popular. But aside from those types of mailings, y

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

u can always partner with a non-competitor (or two or three) that offer a complementary or simila

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

product/service with the same target market as yours. By splitting the cost of the mailing, you

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

till get your message out, but at a much-reduced cost.

JV Inserts/Flyers/Circulars – Similar to

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

V mailings, you could arrange to have your flyer, insert, or circular inserted into another publi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ation already being mailed. This “hitching a ride” approach works best when your audience is targ

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ted, although newspaper inserts are popular with local bricks and mortar businesses. The JV part

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

omes into play when you pay so much per lead or a percentage of all sales resulting from the arra

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

gement. Depending on your price structure, you can pay a percentage of the first sale only, or a

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

iered approach where a smaller percentage is paid for all first year purchases, a percentage of t

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e back-end purchase, etc. You need to determine what types of deals bring in the biggest profits

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

or you, while still providing a valuable incentive for your JV partners. And that really goes for

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

any type of deal.

JV a Mini-Seminar or Teleseminar – Using the lawyer/accountant example again,

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

he two could get together and hold a seminar for new business owners, offering a package deal for

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

both of their services.

Sell Your JV – When you have an income stream from a JV deal you have wo

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ked out, you can always sell the rights to that deal to someone else. Just like a money-making we

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

site that you can sell, JVs that have a positive cash flow are assets in their own right.

JV Dea

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

s to Observe and Learn From a Guru – Basically, you can act as a broker or middle agent between a

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

person with a certain expertise and others who want to learn from the expert.

to be continued...

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/31593/mainsubjects-Joint-Ventures--Part-IV.html">Joint Ventures - Part IV</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/31593/mainsubjects-Joint-Ventures--Part-IV.html]Joint Ventures - Part IV[/url]

Follow Apple's example as a leader in branding. Find out how you can use their techniques to grow your business.

Virtual Assistance is a rapidly growing industry. It offers flexibility, freedom and control.

Tags

Links

Main Subject - Joint Ventures - Part IV

Related Articles: